Q00496 (BXE_CLOBO) Clostridium botulinum

Botulinum neurotoxin type E UniProtKBInterProInteractive Modelling

1251 aa; Sequence (Fasta)

Available Structures

14 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of BoNT/E LC-HN domain in complex with VHH JLE-E5 Heteromer
1-831
ZN;SO4;
Assess
Crystal structure of BoNT/E LC-HN domain in complex with VHH JLE-E9 Heteromer
1-831
Assess
Crystal structure of BoNT/E receptor binding domain in complex with SV2 and VHH Heteromer
Q496J9;
847-1251
NAG;NAG;SO4;PEG;
Assess
Crystal structure of BoNT/E receptor binding domain in complex with SV2, VHH, and sialic acid Heteromer
Q496J9;
847-1251
NAG;NAG;SO4;PG4;SLB;
Assess
Crystal structure of HcE-JLE-G6 Heteromer
847-1251
Assess
Clostridium botulinum type E catalytic domain E212Q mutanthomo-2-mer2-412
ZN;CL;
Assess
Crystal structure of Clostridium botulinum neurotoxin type E catalytic domainhomo-2-mer2-412
ZN;CL;
Assess
Crystal structure of Arg347Ala mutant of botulinum neurotoxin E catalytic domainhomo-2-mer2-412
ZN;CL;
Assess
Crystal structure of Tyr350Ala mutant of Clostridium botulinum neurotoxin E catalytic domainhomo-2-mer2-412
ZN;SO4;
Assess
Crystal structure of Glu158Ala/Thr159Ala/Asn160Ala- a triple mutant of Clostridium botulinum neurot…homo-2-mer2-412
ZN;CL;
Assess
Crystal structure of Glu335Gln mutant of Clostridium botulinum neurotoxin E catalytic domainhomo-2-mer2-412
CL;
Assess
Crystal structure of Glu335Ala mutant of Clostridium botulinum neurotoxin type Ehomo-2-mer2-412
ZN;CL;
Assess
Domain organization in Clostridium butulinum neurotoxin type E is unique: Its implication in faster…monomer2-1251
ZN;NA;ACT;
Assess
Cryo-EM structure of Botulinum neurotoxin serotype Emonomer3-1250
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3ffz.1.Amonomer0.812-1251
ZN;99.60
Assess
4zkt.1.Amonomer0.792-1251
ZN;97.68
Assess
2nz9.1.Amonomer0.661-1251
ZN;39.18
Assess